Bontil Tablet 150 mg (Sodium Risedronate Dihydrate)

Adult dose

1. Adults : Administer 150 mg of risedronate sodium orally once a month. 2. Elderly patients : No dosage adjustment is necessary in elderly patients (over 60 years of age), since the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To allow this medicine to reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled day, follow these instructions. - If the next scheduled dose is 7 days or more away, take 1 tablet the next morning after remembering. Resume the next dose on the originally scheduled day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet of this medicine.

Child dose

The safety and efficacy in children under 18 years of age have not been established.

This drug may irritate the gastrointestinal mucosa; therefore, patients with esophageal disease, gastritis, duodenitis, or ulcers should take it with caution. If symptoms such as dysphagia, chest pain, or heartburn occur after taking this medication, discontinue use immediately and consult a doctor. This drug must be taken with plenty of water, and patients should not lie down for at least 30 minutes after taking it. It is essential to follow the dosing instructions precisely to minimize esophageal irritation, and patients with mental disorders should take it under supervision. Patients with esophageal strictures or achalasia, hypocalcemia, pregnant or breastfeeding women, and those with severe renal impairment should not take this medication. Caution is advised for patients with Barrett's esophagus or dysphagia. Calcium and vitamin D intake is crucial, and treatment should be completed for those with hypocalcemia, parathyroid dysfunction, or vitamin D deficiency before taking this drug. Rare side effects such as jaw necrosis, atypical fractures, and outer ear bone necrosis may occur with long-term use. Patients should consult a doctor immediately if symptoms develop. Taking medications or foods containing calcium, magnesium, or iron at the same time can interfere with absorption, so it is crucial to space these doses. Pregnant or breastfeeding women should avoid this medication or consult a doctor before use, and safety in children under 18 has not been established. Overdosage may lead to symptoms of hypocalcemia and requires immediate medical attention. Keep this medication out of reach of children and do not transfer it to other containers.

• Esophagitis
• esophageal ulcer
• esophageal erosion
• esophageal obstruction
• esophageal perforation
• bleeding
• gastric ulcer
• duodenal ulcer
• dyspepsia
• diarrhea

This drug should be stored in a tightly sealed container to prevent air exposure, and the temperature should be kept between 1°C and 30°C at room temperature. This way, the effectiveness of the medication can be maintained for a long time.

Appearance

Bright blue rectangular film-coated tablet

Package unit

1 tablet (1 tablet/PTP X 1)